Despite significant progress in the prevention and treatment of coronary artery disease (CAD), substantial disparities persist across racial subgroups. While traditional cardiovascular risk factors such as hypertension and diabetes play a role, these differences are further influenced by variations in healthcare access, socioeconomic status, and environmental context. Minority populations remain underrepresented in research and clinical trials, which limits our understanding of these inequities. Focused efforts are needed to identify and act on opportunities that promote equity in cardiovascular care and outcomes.
Kainat et al. (Wed,) studied this question.